相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Monitoring minimal residual disease in acute myeloid leukaemia with NPM1 mutations by quantitative PCR: clonal evolution is a limiting factor
Christina Papadaki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
A dose-dependent tug of war involving the NPM1 leukaemic mutant, nucleophosmin, and ARF
N. Bolli et al.
LEUKEMIA (2009)
Npm1 is a haploinsufficient suppressor of myeloid and lymphoid malignancies in the mouse
Paolo Sportoletti et al.
BLOOD (2008)
MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia
Mojca Jongen-Lavrencic et al.
BLOOD (2008)
An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase
Alexander Kohlmann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Late relapse of acute myeloid leukemia with mutated NPM1 after eight years: evidence of NPM1 mutation stability
G. Meloni et al.
HAEMATOLOGICA (2008)
NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia
Brunangelo Falini et al.
HAEMATOLOGICA (2008)
A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1)
Arcangelo Liso et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice
Brunangelo Falini et al.
HAEMATOLOGICA (2008)
Nucleophosmin and its AML-associated mutant regulate c-Myc turnover through Fbw7γ
Paola Bonetti et al.
JOURNAL OF CELL BIOLOGY (2008)
NPM1-mutated acute myeloid leukaemia occurring in JAK2-V617F+ primary myelofibrosis:: de-novo origin?
L. Pasqualucci et al.
LEUKEMIA (2008)
A western blot assay for detecting mutant nucleophosmin (NPM1) proteins in acute myeloid leukaemia
M. P. Martelli et al.
LEUKEMIA (2008)
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Timothy J. Ley et al.
NATURE (2008)
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F. Schlenk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin
Ramiro Garzon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
In human genome, generation of a nuclear export signal through duplication appears unique to nucleophosmin (NPM1) mutations and is restricted to AML
A. Liso et al.
LEUKEMIA (2008)
Prognostic relevance of FLT3-TKD mutations in AML:: the combination matters -: an analysis of 3082 patients
Ulrike Bacher et al.
BLOOD (2008)
The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia
Rosemary E. Gale et al.
BLOOD (2008)
Pediatric acute myeloid leukemia with NPM1 mutations is characterized by a gene expression profile with dysregulated HOX gene expression distinct from MLL-rearranged leukemias
C. G. Mullighan et al.
LEUKEMIA (2007)
Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts
Luke F. Peterson et al.
BLOOD (2007)
Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants
Niccolo Bolli et al.
CANCER RESEARCH (2007)
Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas
B. Falini et al.
LEUKEMIA (2007)
Absence of nucleophosmin 1 (NPM1) gene mutations in common solid cancers
Eun Goo Jeong et al.
APMIS (2007)
Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML):: biologic and clinical features
Brunangelo Falini et al.
BLOOD (2007)
Lack of nucleophosmin mutation in patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Masayuki Shiseki et al.
LEUKEMIA & LYMPHOMA (2007)
Reply to 'Myeloproliferative disorders with coexisting BCR-ABL translocation and JAK2(V617F) mutation' by Dr Ronald S Go
M. Inami et al.
LEUKEMIA (2007)
Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: impact on WHO classification
Laura Pasqualucci et al.
BLOOD (2006)
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia
Brunangelo Falini et al.
BLOOD (2006)
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations
P. Gorello et al.
LEUKEMIA (2006)
Double induction containing either two courses or one course of high-dose cytarabine plus mitoxantrone and postremission therapy by either autologous stem-cell transplantation or by prolonged maintenance for acute myeloid leukemia
T Büchner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML)
Christian Thiede et al.
BLOOD (2006)
Nucleophosmin mutations in De novo acute myeloid leukemia:: The age-dependent incidences and the stability during disease
WC Chou et al.
CANCER RESEARCH (2006)
Delocalization and destabilization of the Arf tumor suppressor by the leukemia-associated NPM mutant
E Colombo et al.
CANCER RESEARCH (2006)
Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML):: association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance
RGW Verhaak et al.
BLOOD (2005)
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
S Schnittger et al.
BLOOD (2005)
Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics:: interaction with other gene mutations
K Döhner et al.
BLOOD (2005)
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16):: A cancer and leukemia group B study
G Marcucci et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Global approach to the diagnosis of leukemia using gene expression profiling
T Haferlach et al.
BLOOD (2005)
Acute myeloid leukemia bearing cytoplasmic nucleophosmin (NPMc+ AML) shows a distinct gene expression profile characterized by up-regulation of genes involved in stem-cell maintenance
M Alcalay et al.
BLOOD (2005)
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
B Falini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia:: results from Cancer and Leukemia Group B (CALGB 8461)
JC Byrd et al.
BLOOD (2002)
Alterations of the FLT3 gene in acute promyelocytic leukemia: association with diagnostic characteristics and analysis of clinical outcome in patients treated with the Italian AIDA protocol
N Noguera et al.
LEUKEMIA (2002)
Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy
W Kern et al.
LEUKEMIA (2002)
分享论文
